Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes-Reference-Cited by-同舟云学术

Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes

Published:2020-08 Issue: Volume:161 Page:106-115
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Pedro Joana Reis,Moura Liane I.F.,Valério-Fernandes Ângela,Baptista Filipa I.,Gaspar Joana M.,Pinheiro Bárbara S.,Lemos Cristina,Kaufmann Fernanda Neutzling,Morgado Carla,Silva-Santos Carla S. da,Tavares Isaura,Ferreira Samira G.,Carvalho Eugénia,Ambrósio António F.,Cunha Rodrigo A.,Duarte João M.N.,Köfalvi Attila

Funder

Fundação para a Ciência e a Tecnologia

“la Caixa” Foundation

Publisher

Elsevier BV

Subject

General Neuroscience

Reference70 articles.

1. Effect of insulin on 3H-deoxyglucose uptake into brain slices and synaptosomal preparations from different brain regions;Abdul-Ghani;Eur. J. Sci. Res.,2007

2. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB1 and CB2 receptors in the mouse hippocampus;Andó;Neurochem. Int.,2012

3. Synaptic functions of endocannabinoid signaling in health and disease;Araque;Neuropharmacology,2017

4. The source of cerebral insulin;Banks;Eur. J. Pharmacol.,2004

5. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy;Barutta;Diabetes,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice;Neurochemical Research;2023-10-04

2. Loss of brain energy metabolism control as a driver for memory impairment upon insulin resistance;Biochemical Society Transactions;2023-01-06

3. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases;Cannabis and Cannabinoid Research;2021-06-01